‌

US Patent 10292987 Heterocyclic amides as kinase inhibitors

Patent 10292987 was granted and assigned to GlaxoSmithKline on May, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

GlaxoSmithKline

Current Assignee

GlaxoSmithKline

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10292987

Patent Inventor Names

Robert Singhaus, Jr.0

Lara Kathryn Leister0

Patrick M. Eidam0

Philip Anthony Harris0

Ami Lakdawala Shah0

Attiq Rahman0

Bryan Wayne King0

Clark A. Sehon0

...

Date of Patent

May 21, 2019

Patent Application Number

15459141

Date Filed

March 15, 2017

Patent Primary Examiner

‌

Craig D Ricci

Patent abstract

Disclosed are compounds having the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10292987 Heterocyclic amides as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API